LEGAL PROCEEDINGS - Intellectual Property (Details)	Apr. 10, 2026 claim	Dec. 09, 2025 claim	Apr. 28, 2025 claim	Mar. 20, 2025 claim	Jan. 10, 2025	Apr. 05, 2024 claim	May 15, 2023 patent case	Sep. 10, 2021 claim	Feb. 17, 2020 claim	Jul. 10, 2026 claim	Mar. 05, 2025 claim	Jun. 20, 2024 claim
Norwich I Xifaxan Litigation
Loss Contingencies [Line Items]
Number of lawsuits pending									1
Stay of the approval, period									30 months
Norwich II Xifaxan Litigation
Loss Contingencies [Line Items]
Number of lawsuits pending												1
Stay of the approval, period					30 months
Amneal Xifaxan Litigation
Loss Contingencies [Line Items]
Number of lawsuits pending						1
Stay of approval, period						30 months
The Anticipated Cabtreo Paragraph IV Proceedings
Loss Contingencies [Line Items]
Number of lawsuits pending				1
Stay of the approval, period				30 months
The Anticipated Zydus Cabtreo Paragraph IV Proceedings
Loss Contingencies [Line Items]
Number of lawsuits pending	1
Stay of the approval, period	30 months
Sun Pharmaceuticals, Inc. \| Subsequent Event
Loss Contingencies [Line Items]
Number of lawsuits pending										1
Sandoz Canada Inc.
Loss Contingencies [Line Items]
Number of lawsuits pending											1
Lumify Paragraph I V Proceedings Slayback ANDA Litigation
Loss Contingencies [Line Items]
Number of lawsuits pending							1	1
Stay of the approval, period								30 months
Loss contingency, patents allegedly infringed, number \| patent							2
Lumify Paragraph I V Proceedings Somerset ANDA Litigation \| Bausch + Lomb
Loss Contingencies [Line Items]
Number of lawsuits pending			1
Stay of the approval, period			30 months
Lumify Paragraph I V Proceedings Gland ANDA Litigation \| Bausch + Lomb
Loss Contingencies [Line Items]
Number of lawsuits pending		1	1
Stay of the approval, period		30 months	30 months